Your browser doesn't support javascript.
loading
Seroepidemiology of Borrelia burgdorferi s.l. among German National Cohort (NAKO) Participants, Hanover.
Hassenstein, Max J; Janzen, Irina; Krause, Gérard; Harries, Manuela; Melhorn, Vanessa; Kerrinnes, Tobias; Kemmling, Yvonne; Castell, Stefanie.
Afiliación
  • Hassenstein MJ; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.
  • Janzen I; PhD Programme "Epidemiology" Braunschweig-Hannover, Germany.
  • Krause G; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.
  • Harries M; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.
  • Melhorn V; German Center for Infection Research (DZIF), Braunschweig, Germany.
  • Kerrinnes T; Hanover Medical School (MHH), 30625 Hannover, Germany.
  • Kemmling Y; TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture of the Hannover Medical School and Helmholtz Centre for Infection Research, 30625 Hannover, Germany.
  • Castell S; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.
Microorganisms ; 10(11)2022 Nov 17.
Article en En | MEDLINE | ID: mdl-36422355
ABSTRACT
Lyme borreliosis is the leading tick-related illness in Europe, caused by Borrelia Burgdorferi s.l. Lower Saxony, Germany, including its capital, Hanover, has a higher proportion of infected ticks than central European countries, justifying a research focus on the potential human consequences. The current knowledge gap on human incident infections, particularly in Western Germany, demands serological insights, especially regarding a potentially changing climate-related tick abundance and activity. We determined the immunoglobulin G (IgG) and immunoglobulin M (IgM) serostatuses for 8009 German National Cohort (NAKO) participants from Hanover, examined in 2014-2018. We used an enzyme-linked immunosorbent assay (ELISA) as the screening and a line immunoblot as confirmation for the Borrelia Burgdorferi s.l. antibodies. We weighted the seropositivity proportions to estimate general population seropositivity and estimated the force of infection (FOI). Using logistic regression, we investigated risk factors for seropositivity. Seropositivity was 3.0% (IgG) and 2.1% (IgM). The FOI varied with age, sharply increasing in participants aged ≥40 years. We confirmed advancing age and male sex as risk factors. We reported reduced odds for seropositivity with increasing body mass index and depressive symptomatology, respectively, pointing to an impact of lifestyle-related behaviors. The local proportion of seropositive individuals is comparable to previous estimates for northern Germany, indicating a steady seroprevalence.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Microorganisms Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Microorganisms Año: 2022 Tipo del documento: Article País de afiliación: Alemania